Mazandaran University of Medical Sciences

Iran

Country: Iran

Ownership: Private

Established: 1988-01-01

Employees: -

Market Cap: -

Website: http://wwww.mazums.ac.ir

Clinical Trials

Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children with Palmoplantar Wart

Not Applicable

Not yet recruiting

Conditions: Common Warts

Interventions: Drug: Topical 5% fluorouracil cream
Drug: Topical 0.005% calcipotriol ointment
Drug: Placebo

First Posted Date: 2024-12-17

Last Posted Date: 2024-12-17

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT06737406

Locations: 🇮🇷
Iran, Sari, Mazandaran, Iran, Islamic Republic of

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Phase 2

Not yet recruiting

Conditions: Ischemic Stroke
Transient Ischemic Attack

Interventions: Drug: Ticagrelor 60 + Aspirin
Drug: Ticagrelor 90 + aspirin

First Posted Date: 2024-10-22

Last Posted Date: 2024-10-22

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT06653348

Comparison Study of Electrocardiogram Indexes in Patients With Epilepsy, Patients With First Seizure and Normal Population

Completed

Conditions: Patients With Epilepsy
Patients With First Seizure
Normal Population

Interventions: Diagnostic Test: Electrocardiography

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT06608784

Locations: 🇮🇷
Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

Completed

Conditions: Treatment of Idiopathic Generalized Epilepsy

Interventions: Drug: Levetiracetam
Drug: Sodium valproate

First Posted Date: 2024-05-01

Last Posted Date: 2024-05-02

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 169

Registration Number: NCT06393309

Locations: 🇮🇷
Bu Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Not Applicable

Recruiting

Conditions: Atopic Dermatitis

Interventions: Drug: Baricitinib 4 MG
Drug: Azathioprine 1.5-2.5 mg/kg

First Posted Date: 2023-08-01

Last Posted Date: 2024-05-20

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT05969730

Locations: 🇮🇷
Iran, Sari, Mazandaran, Iran, Islamic Republic of

Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy

Phase 4

Completed

Conditions: Epilepsy
Treatment

Interventions: Drug: Probiotic

First Posted Date: 2021-12-16

Last Posted Date: 2022-01-11

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 42

Registration Number: NCT05160350

Locations: 🇮🇷
Bu Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of

Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis

Phase 2

Conditions: Magnetic Resonance Imaging
Multiple Sclerosis, Relapsing-Remitting
Methylprednisolone

Interventions: Drug: Methylprednisolone succinate
Drug: Normal saline

First Posted Date: 2021-07-28

Last Posted Date: 2021-08-05

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 104

Registration Number: NCT04979650

Locations: 🇮🇷
Mazandaran University of medical sciences, Sari, Mazandaran, Iran, Islamic Republic of

Ciprofloxacin in Drug-resistant Epilepsy

Not Applicable

Completed

Conditions: Epilepsy Intractable

Interventions: Drug: Ciprofloxacin Oral Product

First Posted Date: 2021-02-21

Last Posted Date: 2021-06-07

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 23

Registration Number: NCT04763070

Locations: 🇮🇷
Bu Ali Sina hospital, Sari, Mazandaran, Iran, Islamic Republic of

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Phase 3

Completed

Conditions: Ischemic Stroke
Transient Ischemic Attack

Interventions: Drug: Clopidogrel 75 mg
Drug: Ticagrelor 90mg

First Posted Date: 2021-02-04

Last Posted Date: 2023-10-19

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT04738097

Locations: 🇮🇷
Athena Sharifi Razavi, Sari, Mazandaran, Iran, Islamic Republic of
🇮🇷
Bou-Ali Sina hospital , Mazandarn University of Medical Science, Sari, Iran, Islamic Republic of

Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial

Not Applicable

Conditions: Coronavirus Infections

Interventions: Biological: Convalescent Plasma

First Posted Date: 2020-03-31

Last Posted Date: 2020-03-31

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 30

Registration Number: NCT04327349

Locations: 🇮🇷
Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy